A urine test developed by scientists at the University of Cambridge has moved a step closer to clinical use following new findings revealing it could do more than first thought. Originally designed to detect early signs of lung cancer and treatment resistance, the test shows potential in identifying biological signals associated with pulmonary fibrosis—a serious condition where early diagnosis remains a major challenge.